Neo Cremar Co., Ltd.
Financials
Valuation Metrics
Neo Cremar Co., Ltd.'s Market Cap is ₩295B. At end of 2025 it was ₩743B. Ranked #2099 of 2,421 in KR market (top 87%), #1347 of 1,640 on KOSDAQ (top 82%), #70 of 84 in Food, Beverage & Tobacco (top 83%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 29.55B KRW | KR#2,099/2,421 Sec#70/84 |
| Revenue | 81.63B KRW | KR#1,543/2,421 Sec#70/84 |
| Net Income | 7.31B KRW | KR#1,077/2,421 Sec#42/84 |
| Total Assets | 189.37B KRW | KR#1,351/2,421 Sec#61/84 |
| Net Assets | 149.96B KRW | KR#1,134/2,421 Sec#50/84 |
| Employees | 69 | KR#1,887/2,421 Sec#71/84 |
| Value | ||
| P/E | 4.04x | KR#251/2,421 Sec#17/84 |
| P/B | 0.20x | KR#111/2,421 Sec#8/84 |
| PEG | 0.02x | KR#190/2,421 Sec#9/84 |
| P/S | 0.36x | KR#702/2,421 Sec#57/84 |
| EV/EBITDA | 6.20x | KR#318/2,421 Sec#16/84 |
| FCF Yield | 50.65% | KR#76/2,421 Sec#10/84 |
| Profitability | ||
| ROE | 4.87% | KR#1,114/2,421 Sec#37/84 |
| ROA | 3.86% | KR#902/2,421 Sec#26/84 |
| Op. Margin | 4.38% | KR#1,042/2,421 Sec#39/84 |
| Revenue Growth | 15.14% | KR#681/2,421 Sec#8/84 |
| Earnings Growth | 188.19% | KR#257/2,421 Sec#10/84 |
| Financial Health | ||
| Debt Ratio | 26.28% | KR#507/2,421 Sec#10/84 |
| Total Debt | 12.88B KRW | KR#1,545/2,421 Sec#70/84 |
| FCF | 14.97B KRW | KR#601/2,421 Sec#40/84 |
| Cash | 20.25B KRW | KR#1,245/2,421 Sec#52/84 |
| Current Ratio | 4.55x | KR#323/2,421 Sec#2/84 |
| Net Debt/EBITDA | -2.06x | KR#232/2,421 Sec#3/84 |
| Dividend | ||
| Div. Yield | 2.17% | KR#839/2,421 Sec#49/84 |
| Performance | ||
| 1Y Return | -75.83% | KR#2,338/2,421 Sec#81/84 |
| 1M Return | -9.32% | KR#2,064/2,421 Sec#74/84 |
| From 52W High | -78.58% | KR#2,329/2,421 Sec#82/84 |
| 1Y MDD | -78.82% | KR#2,275/2,421 Sec#82/84 |
| Trading | ||
| Volume | 20,679 shares | KR#1,575/2,421 Sec#40/84 |
| Trading Value | 47.9M KRW | KR#1,848/2,421 Sec#57/84 |
| Foreign Own. | 3.59% | KR#1,139/2,421 Sec#40/84 |
| Per Share | ||
| EPS | 578 KRW | KR#939/2,421 Sec#40/84 |
| BPS | 11,851 KRW | KR#863/2,421 Sec#46/84 |
Company Info
Established in 2007 with functional sugar and peptide product manufacturing and product distribution as its main businesses, the company was listed on KOSDAQ in 2019. Through its main subsidiary, BBC Co., Ltd., it operates material businesses such as monofilament and functional air filters, and healthcare businesses including toothbrushes. As a microbiome-based functional food material company, it produces galactooligosaccharides and low molecular weight yeast peptides, leading the market by globally launching organic galactooligosaccharides for the first time. Neocrema was established in 2007 and is headquartered in Gangnam-gu, Seoul.